|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,160 GBX | +1.31% |
|
+7.41% | +70.59% |
| 10/04 | 4basebio to supply synthetic DNA for mRNA vaccine program | AN |
| 10/04 | 4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program | CI |
4basebio PLC announced the supply of its HQ synthetic DNA to a Tier 1 Pharma Company. Following successful completion of an opDNA? evaluation study, client has now progressed to HQ opDNA?
for late preclinical studies for an mRNA vaccine program. Supply of GMP grade material for clinical trials is anticipated in Q3.
| 1st Jan change | Capi. | |
|---|---|---|
| +70.59% | 186M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
4BASEBIO PLC 
